D05.1 Intraductal carcinoma in situ of breast

Name of the Condition

• Intraductal carcinoma in situ of breast
• Often referred to as Ductal Carcinoma In Situ (DCIS)

Summary

Intraductal carcinoma in situ (DCIS) is a non-invasive breast cancer where abnormal cells are confined to the milk ducts of the breast. It is considered the earliest form of breast cancer and is typically detected during routine screening.

Causes

The exact cause of DCIS is not fully understood, but it involves genetic mutations in the DNA of breast duct cells that lead to uncontrolled cell growth. Hormonal imbalances and genetic predispositions may contribute to its development.

Risk Factors

• Age: More common in women over 50.
• Family history of breast cancer.
• Genetic mutations such as BRCA1 and BRCA2.
• Prolonged estrogen exposure.
• Previous breast conditions like atypical hyperplasia.

Symptoms

• DCIS often has no noticeable symptoms.
• It may occasionally present as a breast lump or nipple discharge, but these are rare.

Diagnosis

Mammography is the primary tool for detecting DCIS, often showing microcalcifications. A biopsy is required to confirm the diagnosis by examining tissue samples under a microscope.

Treatment Options

• Surgery: Lumpectomy or mastectomy, depending on the extent of the DCIS.
• Radiation therapy is often recommended after surgery to reduce recurrence risk.
• Hormonal therapy may be used if the cancer is hormone receptor-positive.

Prognosis and Follow-Up

DCIS has a high survival rate when treated promptly. Regular follow-up with mammograms and clinical exams is essential to monitor for recurrence.

Complications

• Potential complications include infection, bleeding, or lymphedema after surgery.
• There is a risk of recurrence, which may require additional treatment.

Lifestyle & Prevention

• Maintain a healthy weight and limit alcohol consumption.
• Engage in regular physical activity.
• Discuss breast cancer screening guidelines with a healthcare provider based on individual risk factors.

When to Seek Professional Help

• Consult a healthcare provider if a new breast lump, nipple discharge, or skin changes are noticed.
• Seek care if routine mammogram results indicate abnormalities.

Tips for Medical Coders

• Use code D05.1 for intraductal carcinoma in situ of the breast. Ensure documentation specifies the breast involved (e.g., left, right, or unspecified) and any laterality details. Verify that the diagnosis aligns with clinical findings and biopsy results to support accurate coding.